These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19037032)

  • 21. Understanding the mechanism of learning enhancement: NMDA and GABA receptor expression.
    Toso L; Johnson A; Bissell S; Roberson R; Abebe D; Spong CY
    Am J Obstet Gynecol; 2007 Sep; 197(3):267.e1-4. PubMed ID: 17826414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
    Bassan M; Zamostiano R; Davidson A; Pinhasov A; Giladi E; Perl O; Bassan H; Blat C; Gibney G; Glazner G; Brenneman DE; Gozes I
    J Neurochem; 1999 Mar; 72(3):1283-93. PubMed ID: 10037502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.
    Poggi SH; Goodwin K; Hill JM; Brenneman DE; Tendi E; Schinelli S; Abebe D; Spong CY
    Am J Obstet Gynecol; 2003 Sep; 189(3):790-3. PubMed ID: 14526315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome.
    Hill JM; Ades AM; McCune SK; Sahir N; Moody EM; Abebe DT; Crnic LS; Brenneman DE
    Exp Neurol; 2003 Sep; 183(1):56-65. PubMed ID: 12957488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinatal Natural History of the Ts1Cje Mouse Model of Down Syndrome: Growth Restriction, Early Mortality, Heart Defects, and Delayed Development.
    Ferrés MA; Bianchi DW; Siegel AE; Bronson RT; Huggins GS; Guedj F
    PLoS One; 2016; 11(12):e0168009. PubMed ID: 27930746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.
    Billingsley CN; Allen JR; Baumann DD; Deitz SL; Blazek JD; Newbauer A; Darrah A; Long BC; Young B; Clement M; Doerge RW; Roper RJ
    Am J Med Genet A; 2013 Aug; 161A(8):1866-74. PubMed ID: 23843306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective peptides influence cytokine and chemokine alterations in a model of fetal alcohol syndrome.
    Roberson R; Kuddo T; Benassou I; Abebe D; Spong CY
    Am J Obstet Gynecol; 2012 Dec; 207(6):499.e1-5. PubMed ID: 23174390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis.
    Busciglio J; Pelsman A; Helguera P; Ashur-Fabian O; Pinhasov A; Brenneman DE; Gozes I
    Curr Pharm Des; 2007; 13(11):1091-8. PubMed ID: 17430172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome.
    Spong CY; Abebe DT; Gozes I; Brenneman DE; Hill JM
    J Pharmacol Exp Ther; 2001 May; 297(2):774-9. PubMed ID: 11303069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryonic statistical analyses reveal 2 growth phenotypes in mouse models of Down syndrome.
    Adams AD; Lin J; Bianchi DW; Bishop L; Sato T; Baxter LL; Hoffmann V; Koehly L; Guedj F
    Am J Obstet Gynecol; 2024 Feb; 230(2):258.e1-258.e11. PubMed ID: 37544351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal, but not Postnatal, Curcumin Administration Rescues Neuromorphological and Cognitive Alterations in Ts65Dn Down Syndrome Mice.
    Rueda N; Vidal V; García-Cerro S; Puente A; Campa V; Lantigua S; Narcís O; Bartesaghi R; Martínez-Cué C
    J Nutr; 2020 Sep; 150(9):2478-2489. PubMed ID: 32729926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity.
    Wilkemeyer MF; Chen SY; Menkari CE; Brenneman DE; Sulik KK; Charness ME
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8543-8. PubMed ID: 12808140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-SAL and NAP: Two Peptides Sharing a SIP Domain.
    Gozes I; Sragovich S; Schirer Y; Idan-Feldman A
    J Mol Neurosci; 2016 Jun; 59(2):220-31. PubMed ID: 26816081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome.
    Kida E; Walus M; Albertini G; Golabek AA
    Brain Res; 2021 Sep; 1766():147535. PubMed ID: 34043998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
    Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
    Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein.
    Sari Y; Gozes I
    Brain Res Rev; 2006 Aug; 52(1):107-18. PubMed ID: 16488478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome.
    Shichiri M; Yoshida Y; Ishida N; Hagihara Y; Iwahashi H; Tamai H; Niki E
    Free Radic Biol Med; 2011 Jun; 50(12):1801-11. PubMed ID: 21447382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Raspanti A; Giacomini A; Guidi S; Emili M; Ciani E; Giuliani A; Bighinati A; Calzà L; Magistretti J; Bartesaghi R
    Neurobiol Dis; 2017 Jul; 103():11-23. PubMed ID: 28359846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased male reproductive success in Ts65Dn "Down syndrome" mice.
    Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH
    Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.